Literature DB >> 11916499

A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma.

Greg D Eley1, Jill L Reiter, Ajay Pandita, Soyeon Park, Robert B Jenkins, Nita J Maihle, C David James.   

Abstract

Cumulative information available about the organization of amplified chromosomal regions in human tumors suggests that the amplification repeat units, or amplicons, can be of a simple or complex nature. For the former, amplified regions generally retain their native chromosomal configuration and involve a single amplification target sequence. For complex amplicons, amplified DNAs usually undergo substantial reorganization relative to the normal chromosomal regions from which they evolve, and the regions subject to amplification may contain multiple target sequences. Previous efforts to characterize the 7p11.2 epidermal growth factor receptor ) amplicon in glioblastoma have relied primarily on the use of markers positioned by linkage analysis and/or radiation hybrid mapping, both of which are known to have the potential for being inaccurate when attempting to order loci over relatively short (<1 Mb) chromosomal regions. Due to the limited resolution of genetic maps that have been established through the use of these approaches, we have constructed a 2-Mb bacterial and P1-derived artificial chromosome (BAC-PAC) contig for the EGFR region and have applied markers positioned on its associated physical map to the analysis of 7p11.2 amplifications in a series of glioblastomas. Our data indicate that EGFR is the sole amplification target within the mapped region, although there are several additional 7p11.2 genes that can be coamplified and overexpressed with EGFR. Furthermore, these results are consistent with EGFR amplicons retaining the same organization as the native chromosome 7p11.2 region from which they are derived.

Entities:  

Mesh:

Year:  2002        PMID: 11916499      PMCID: PMC1920657          DOI: 10.1093/neuonc/4.2.86

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  23 in total

1.  Epidermal growth factor receptor-coamplified and overexpressed protein (VOPP1) is a putative oncogene in gastric cancer.

Authors:  Caiping Gao; Minghui Pang; Zhou Zhou; Size Long; Dandan Dong; Jiyun Yang; Mei Cao; Chumin Zhang; Shengxi Han; Liangping Li
Journal:  Clin Exp Med       Date:  2014-11-15       Impact factor: 3.984

2.  Intracellular localization of GASP/ECOP/VOPP1.

Authors:  Alexander Baras; Christopher A Moskaluk
Journal:  J Mol Histol       Date:  2010-06-23       Impact factor: 2.611

3.  pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations.

Authors:  Gabriella Aquino; Giuseppe Pannone; Angela Santoro; Giuseppina Liguori; Renato Franco; Rosario Serpico; Gianluca Florio; Alfredo De Rosa; Marilena Mattoni; Valentina Cozza; Gerardo Botti; Simona Losito; Francesco Longo; Stefania Staibano; Giovanni Cuda; Lorenzo Lo Muzio; Carolina Sbordone; Pantaleo Bufo; Anna Grimaldi; Michele Caraglia; Marina Di Domenico
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

4.  Gene signatures of postoperative atrial fibrillation in atrial tissue after coronary artery bypass grafting surgery in patients receiving β-blockers.

Authors:  Miklos D Kertai; Wenjing Qi; Yi-Ju Li; Frederick W Lombard; Yutao Liu; Michael P Smith; Mark Stafford-Smith; Mark F Newman; Carmelo A Milano; Joseph P Mathew; Mihai V Podgoreanu
Journal:  J Mol Cell Cardiol       Date:  2016-02-06       Impact factor: 5.000

5.  Something old and something new about molecular diagnostics in gliomas.

Authors:  Craig Horbinski
Journal:  Surg Pathol Clin       Date:  2012-12-01

6.  Tumor prognostic factors and the challenge of developing predictive factors.

Authors:  Emma B Holliday; Erik P Sulman
Journal:  Curr Oncol Rep       Date:  2013-02       Impact factor: 5.075

7.  MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activity.

Authors:  Hongping Xia; Yukui Yan; Minghua Hu; Yaxian Wang; Yongsheng Wang; Yi Dai; Jianming Chen; Guangfu Di; Xiaobing Chen; Xiaochun Jiang
Journal:  Neuro Oncol       Date:  2012-12-14       Impact factor: 12.300

8.  Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes.

Authors:  Christopher G Duncan; Patrick J Killela; Cathy A Payne; Benjamin Lampson; William C Chen; Jeff Liu; David Solomon; Todd Waldman; Aaron J Towers; Simon G Gregory; Kerrie L McDonald; Roger E McLendon; Darell D Bigner; Hai Yan
Journal:  Oncotarget       Date:  2010-08

9.  Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.

Authors:  Zheming Lu; Lei Zhou; Patrick Killela; Ahmed B Rasheed; Chunhui Di; William E Poe; Roger E McLendon; Darell D Bigner; Christopher Nicchitta; Hai Yan
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

10.  Unexpected diversity in Shisa-like proteins suggests the importance of their roles as transmembrane adaptors.

Authors:  Jimin Pei; Nick V Grishin
Journal:  Cell Signal       Date:  2011-11-18       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.